<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Science Group Plc — News on 6ix</title>
<link>https://6ix.com/company/science-group-plc</link>
<description>Latest news and press releases for Science Group Plc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Fri, 20 Mar 2026 07:01:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/science-group-plc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835eb6e78dffbe2df12aace.webp</url>
<title>Science Group Plc</title>
<link>https://6ix.com/company/science-group-plc</link>
</image>
<item>
<title>Chair Shareholding</title>
<link>https://6ix.com/company/science-group-plc/news/chair-shareholding</link>
<guid isPermaLink="true">https://6ix.com/company/science-group-plc/news/chair-shareholding</guid>
<pubDate>Fri, 20 Mar 2026 07:01:00 GMT</pubDate>
<description>Science Group PLC announced that Executive Chair Martyn Ratcliffe now holds 8,042,080 shares, representing 19.4% of the company's issued share capital, which currently stands at 41,364,312 ordinary shares excluding treasury shares, following a share buy-back programme.
Disclaimer*</description>
</item>
<item>
<title>Audited Results for Year Ended 31 December 2025</title>
<link>https://6ix.com/company/science-group-plc/news/audited-results-for-year-ended-31-december-2025</link>
<guid isPermaLink="true">https://6ix.com/company/science-group-plc/news/audited-results-for-year-ended-31-december-2025</guid>
<pubDate>Tue, 17 Mar 2026 07:01:00 GMT</pubDate>
<description>Science Group PLC reported strong audited results for the year ended 31 December 2025, with record adjusted operating profit of £23.1 million, up from £21.5 million in 2024, and revenue of £111.7 million, a slight increase from £110.7 million. The company also achieved a significant pre-tax gain of £24.1 million from a corporate investment, contributing to a record profit before tax of £41.5 million. The balance sheet remains robust with cash reserves of £72.6 million, and the company is recomme</description>
</item>
<item>
<title>Total Voting Rights</title>
<link>https://6ix.com/company/science-group-plc/news/total-voting-rights-470</link>
<guid isPermaLink="true">https://6ix.com/company/science-group-plc/news/total-voting-rights-470</guid>
<pubDate>Mon, 02 Mar 2026 07:00:00 GMT</pubDate>
<description>Science Group PLC has announced its total voting rights, stating that its issued share capital, excluding treasury shares, comprises 42,784,312 ordinary shares of 1 penny each. The company currently holds 3,401,562 shares in treasury. This figure of 42,784,312 will serve as the denominator for shareholders to calculate their notification requirements under the FCA's Disclosure and Transparency Rules regarding their interests in the company.
Disclaimer*</description>
</item>
<item>
<title>Transaction in Own Shares</title>
<link>https://6ix.com/company/science-group-plc/news/transaction-in-own-shares-25</link>
<guid isPermaLink="true">https://6ix.com/company/science-group-plc/news/transaction-in-own-shares-25</guid>
<pubDate>Mon, 09 Feb 2026 07:00:00 GMT</pubDate>
<description>Science Group PLC announced on February 9, 2026, that it purchased 11,980 of its ordinary shares on February 6, 2026, at an average price of 542.5 pence per share, representing 0.03% of its voting rights. Following this transaction, the company has 42,908,812 ordinary shares in issue, excluding the 3,277,062 shares held in treasury. This updated share count is to be used by shareholders for notification purposes under FCA rules.
Disclaimer*</description>
</item>
<item>
<title>FY25 Update and FY26 Share Buy-Back Programme</title>
<link>https://6ix.com/company/science-group-plc/news/fy25-update-and-fy26-share-buy-back-programme</link>
<guid isPermaLink="true">https://6ix.com/company/science-group-plc/news/fy25-update-and-fy26-share-buy-back-programme</guid>
<pubDate>Tue, 13 Jan 2026 07:01:00 GMT</pubDate>
<description>Science Group plc anticipates reporting a record adjusted operating profit for 2025, exceeding board expectations due to a recovery in its Services division, particularly in the Medical sector, and a positive return on investment from H1 corporate activity. The company's strong cash position has significantly improved, with gross cash at £72.6 million and net funds at £61.2 million as of December 31, 2025, up from £38.6 million and £26.8 million respectively in the prior year, after returning £1</description>
</item>
<item>
<title>Corporate Brokers</title>
<link>https://6ix.com/company/science-group-plc/news/corporate-brokers</link>
<guid isPermaLink="true">https://6ix.com/company/science-group-plc/news/corporate-brokers</guid>
<pubDate>Tue, 16 Dec 2025 07:01:00 GMT</pubDate>
<description>Science Group plc has appointed Peel Hunt LLP as a joint corporate broker, alongside Panmure Liberum Limited, which will continue as the Group's Nominated Adviser and manage the delegated buy-back programme. The company reiterates its expectation of a strong performance for the year ending 31 December 2025, consistent with its trading update on 13 October 2025, and anticipates providing a further update in mid-January 2026.
Disclaimer*</description>
</item>
<item>
<title>Holding(s) in Company</title>
<link>https://6ix.com/company/science-group-plc/news/holdings-in-company-46</link>
<guid isPermaLink="true">https://6ix.com/company/science-group-plc/news/holdings-in-company-46</guid>
<pubDate>Mon, 24 Nov 2025 15:55:00 GMT</pubDate>
<description>Ruffer LLP has increased its voting rights in Science Group PLC to 17.012329%, representing 7,402,939 shares, up from a previous holding of 16.797130%. This change, effective November 21, 2025, is due to an update in Net Shareable Interests and does not involve financial instruments. Ruffer LLP controls the voting rights for discretionary clients, and this notification signifies a crossing of a notifiable threshold.
Disclaimer*</description>
</item>
<item>
<title>Treasury Shares Issued</title>
<link>https://6ix.com/company/science-group-plc/news/treasury-shares-issued</link>
<guid isPermaLink="true">https://6ix.com/company/science-group-plc/news/treasury-shares-issued</guid>
<pubDate>Mon, 17 Nov 2025 11:45:00 GMT</pubDate>
<description>Science Group plc announced the issuance of 5,000 treasury shares at an average price of 1 pence per share on November 17, 2025, to settle the exercise of share options. Following this transaction, the total number of ordinary shares in issue, excluding treasury shares, stands at 44,072,642, with the company holding 2,113,232 shares in treasury. This updated share count is to be used by shareholders for notification purposes under the FCA's Disclosure Guidance and Transparency Rules.
</description>
</item>
<item>
<title>Trading Update</title>
<link>https://6ix.com/company/science-group-plc/news/trading-update-23</link>
<guid isPermaLink="true">https://6ix.com/company/science-group-plc/news/trading-update-23</guid>
<pubDate>Mon, 13 Oct 2025 06:01:00 GMT</pubDate>
<description>Science Group's trading update for the nine months ended September 30, 2025, indicates continued strong performance. The company maintains a positive outlook, expecting adjusted operating profit to be in line or slightly ahead of expectations for the year ending December 31, 2025. The Group's gross cash stood at £77.6 million, with net funds of £66.0 million after a dividend payment of £3.6 million in July and a £2.5 million tax instalment related to a prior £24.0 million exceptional pre-tax gai</description>
</item>
<item>
<title>Treasury shares issued & PDMR dealing</title>
<link>https://6ix.com/company/science-group-plc/news/treasury-shares-issued-and-pdmr-dealing</link>
<guid isPermaLink="true">https://6ix.com/company/science-group-plc/news/treasury-shares-issued-and-pdmr-dealing</guid>
<pubDate>Wed, 08 Oct 2025 06:01:00 GMT</pubDate>
<description>On October 7, 2025, Science Group plc announced the issuance of 314,334 treasury shares at an average price of 1 pence per share to settle share option exercises. As part of this, Director Dan Edwards acquired 20,000 shares at 1 pence each and then disposed of them at 535 pence each. Director Jon Brett acquired 25,000 shares at 1 pence each, subsequently disposing of 22,000 at 535 pence each; Brett now holds 5,000 shares, representing 0.01% of voting rights. PDMR Sarah Cole acquired 10,000 share</description>
</item>
<item>
<title>Treasury shares issued</title>
<link>https://6ix.com/company/science-group-plc/news/treasury-shares-issued-1</link>
<guid isPermaLink="true">https://6ix.com/company/science-group-plc/news/treasury-shares-issued-1</guid>
<pubDate>Mon, 29 Sep 2025 11:00:00 GMT</pubDate>
<description>Science Group PLC announced on September 29, 2025, the issuance of 30,000 treasury shares at an average price of 1 pence per share. This issuance settles the exercise of share options. Following this announcement, the total number of ordinary shares in issue, excluding treasury shares, is 44,058,508. The company holds 2,127,366 shares in treasury. The figure of 44,058,508 may be used by shareholders to determine if they are required to notify their interest in the Company.
Discl</description>
</item>
<item>
<title>Chairman Shareholding</title>
<link>https://6ix.com/company/science-group-plc/news/chairman-shareholding</link>
<guid isPermaLink="true">https://6ix.com/company/science-group-plc/news/chairman-shareholding</guid>
<pubDate>Fri, 05 Sep 2025 06:00:00 GMT</pubDate>
<description>On September 5, 2025, Science Group PLC announced that Executive Chairman Martyn Ratcliffe sold 1,450,000 shares at a price of 550 pence per share. The total value of the shares sold amounts to £7,975,000. Following the transaction, Mr. Ratcliffe retains 8,042,080 shares, representing 18.2% of the company's voting rights. The sale was conducted to satisfy institutional demand and the company welcomes new institutional shareholders, believing this strengthens the platform for future development. </description>
</item>
<item>
<title>Interim results for 6 months ended 30 June 2025</title>
<link>https://6ix.com/company/science-group-plc/news/interim-results-for-6-months-ended-30-june-2025</link>
<guid isPermaLink="true">https://6ix.com/company/science-group-plc/news/interim-results-for-6-months-ended-30-june-2025</guid>
<pubDate>Mon, 28 Jul 2025 06:01:00 GMT</pubDate>
<description>Interim results for 6 months ended 30 June 2025.</description>
</item>
<item>
<title>Change of Adviser & Notice of Interim Results</title>
<link>https://6ix.com/company/science-group-plc/news/change-of-adviser-and-notice-of-interim-results</link>
<guid isPermaLink="true">https://6ix.com/company/science-group-plc/news/change-of-adviser-and-notice-of-interim-results</guid>
<pubDate>Tue, 15 Jul 2025 06:01:00 GMT</pubDate>
<description>Change of Adviser & Notice of Interim Results.</description>
</item>
<item>
<title>Ricardo Investment and Share Buy-Back</title>
<link>https://6ix.com/company/science-group-plc/news/ricardo-investment-and-share-buy-back</link>
<guid isPermaLink="true">https://6ix.com/company/science-group-plc/news/ricardo-investment-and-share-buy-back</guid>
<pubDate>Thu, 19 Jun 2025 06:00:00 GMT</pubDate>
<description>Ricardo Investment and Share Buy-Back.</description>
</item>
<item>
<title>Ricardo Investment Realisation</title>
<link>https://6ix.com/company/science-group-plc/news/ricardo-investment-realisation</link>
<guid isPermaLink="true">https://6ix.com/company/science-group-plc/news/ricardo-investment-realisation</guid>
<pubDate>Wed, 11 Jun 2025 06:20:00 GMT</pubDate>
<description>Ricardo Investment Realisation.</description>
</item>
<item>
<title>Ricardo EGM – ISS Recommendation</title>
<link>https://6ix.com/company/science-group-plc/news/ricardo-egm-iss-recommendation</link>
<guid isPermaLink="true">https://6ix.com/company/science-group-plc/news/ricardo-egm-iss-recommendation</guid>
<pubDate>Mon, 02 Jun 2025 06:01:00 GMT</pubDate>
<description>Ricardo EGM – ISS Recommendation.</description>
</item>
<item>
<title>Ricardo Investment and Open Letter</title>
<link>https://6ix.com/company/science-group-plc/news/ricardo-investment-and-open-letter</link>
<guid isPermaLink="true">https://6ix.com/company/science-group-plc/news/ricardo-investment-and-open-letter</guid>
<pubDate>Wed, 28 May 2025 06:00:00 GMT</pubDate>
<description>Ricardo Investment and Open Letter.</description>
</item>
<item>
<title>Result of AGM</title>
<link>https://6ix.com/company/science-group-plc/news/result-of-agm-475</link>
<guid isPermaLink="true">https://6ix.com/company/science-group-plc/news/result-of-agm-475</guid>
<pubDate>Wed, 21 May 2025 09:30:00 GMT</pubDate>
<description>Result of AGM.</description>
</item>
<item>
<title>AGM Update</title>
<link>https://6ix.com/company/science-group-plc/news/agm-update-15</link>
<guid isPermaLink="true">https://6ix.com/company/science-group-plc/news/agm-update-15</guid>
<pubDate>Wed, 21 May 2025 06:01:00 GMT</pubDate>
<description>AGM Update.</description>
</item>
</channel>
</rss>